- | TFF Pharmaceuticals
CEO Glenn Mattes, VP of Product Development and Manufacturing Dr. John Koleng, and their team are disrupting traditional pharmaceutical development and manufacturing with exciting new technology.
Mattes says there isn’t an official founding date for TFF Pharmaceuticals (NASDAQ TFFP) as the company sprung from another Austin-based organization known as Lung Therapeutics circa 2017.
- | EMulate Therapeutics
Biopharma Makes Progress against a Childhood Killer: Pediatric Glioma
A unique approach to pediatric glioma treatment comes from EMulate Therapeutics, a clinical-stage therapeutic device company. EMulate’s proprietary platform uses ultra-low radio frequency energy (ulRFE®) to record and replay a molecule’s digital fingerprint.
- | Ring Therapeutics
Biotech turns to new and strange viruses to overcome gene therapy’s limitations
The fluorescent orange sticker atop the white machine reads “BIOHAZARD,” but it’s a bit of a misnomer. Although Earth abounds with pathogens that can maim, kill, paralyze, and poison, the specimens inside this machine — being pipetted left and right behind glass for sequencing — are probably the most innocuous human viruses you will ever encounter.
- | IMV
Cancer Vaccines Push Toward Viability with New Approaches and Targets
In another advance, IMV Inc. recently announced positive data in metastatic bladder cancer patients using its cancer vaccine, Maveropepimut-S (MVP-S) – also known as DPX-Survivac.
- | BlueSphere Bio
Calibr, Synthego, BlueSphere and More Showcase Data at CAR-TCR Summit
BlueSphere Bio presented a poster describing its TCXpress and iTCXpress high-through platforms for TCRs.
- | PepGen
BOSTINNO’S 2022 FIRE AWARDS
The day you’ve been waiting for has arrived. It’s time to meet the 2022 honorees of the BostInno Fire Awards.
- | Alto Neuroscience
Better brain biology will deliver better medicines
What patients say they are feeling is also a possible source of confusion. Amit Etkin, the CEO of Alto Neuroscience, points out that in Asia the symptoms that Western psychiatry uses to diagnose depression—low moo
- | PepGen
PepGen’s Michelle Mellion is Redefining Success in Clinical Development
Michelle Mellion, M.D., newly-appointed SVP and head of clinical development at PepGen, began her career working to deliver the best possible to care to patients and education to medical students. Now she is working to ensure the patient’s voice is heard throughout the drug development process.